0001628280-22-027577.txt : 20221101
0001628280-22-027577.hdr.sgml : 20221101
20221101163118
ACCESSION NUMBER: 0001628280-22-027577
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221031
FILED AS OF DATE: 20221101
DATE AS OF CHANGE: 20221101
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BISARO PAUL
CENTRAL INDEX KEY: 0001237253
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26642
FILM NUMBER: 221350882
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MYRIAD GENETICS INC
CENTRAL INDEX KEY: 0000899923
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 870494517
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 320 WAKARA WAY
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84108
BUSINESS PHONE: 801-584-3600
MAIL ADDRESS:
STREET 1: 320 WAKARA WAY
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84108
4
1
wf-form4_166733465434274.xml
FORM 4
X0306
4
2022-10-31
0
0000899923
MYRIAD GENETICS INC
MYGN
0001237253
BISARO PAUL
320 WAKARA WAY
SALT LAKE CITY
UT
84108
1
0
0
0
Common Stock
2022-10-31
4
A
0
16875
0
A
16875
D
Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests on the anniversary of the date of grant.
By: Justin Hunter For: Paul Bisaro
2022-11-01